HealthMore in Health→
Early Dravet syndrome gene therapy data point to seizure reductions, with major caveats
Key Takeaways
- Encoded Therapeutics reported a 76% seizure reduction in Dravet syndrome.
- The supplied excerpt says the result was observed in only three patients.
- The data are promising but far too early for broad conclusions.
DE
DT Editorial Team··via endpoints.news